What is the appropriate antibiotic regimen for treating or providing prophylaxis for group B Streptococcus (Streptococcus agalactiae)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Treatment for Group B Streptococcus

For intrapartum GBS prophylaxis, penicillin G (5 million units IV initial dose, then 2.5-3.0 million units IV every 4 hours until delivery) or ampicillin (2 g IV initial dose, then 1 g IV every 4 hours until delivery) are the first-line antibiotics, and must be administered at least 4 hours before delivery to achieve adequate protection against early-onset neonatal disease. 1

Standard Prophylaxis Regimen

For non-allergic patients:

  • Penicillin G: 5 million units IV loading dose, followed by 2.5-3.0 million units IV every 4 hours until delivery 1
  • Ampicillin: 2 g IV loading dose, followed by 1 g IV every 4 hours until delivery 1
  • Both regimens demonstrate 91% effectiveness at term and 86% effectiveness in preterm deliveries when administered ≥4 hours before birth 2

Penicillin-Allergic Patients: Risk Stratification Required

The antibiotic choice depends critically on allergy severity 1, 3:

Low-Risk Penicillin Allergy (No History of Anaphylaxis, Angioedema, Respiratory Distress, or Urticaria)

  • Cefazolin: 2 g IV initial dose, then 1 g IV every 8 hours until delivery 1
  • Cefazolin is preferred because pharmacologic data demonstrate effective intraamniotic concentrations 1

High-Risk Penicillin Allergy (History of Anaphylaxis, Angioedema, Respiratory Distress, or Urticaria)

These patients must NOT receive penicillin, ampicillin, or cefazolin 1, 3. The choice depends on GBS susceptibility testing:

If GBS isolate is susceptible to both clindamycin AND erythromycin:

  • Clindamycin: 900 mg IV every 8 hours until delivery 1, 3

If GBS isolate is susceptible to clindamycin but resistant to erythromycin:

  • Clindamycin 900 mg IV every 8 hours may be used ONLY if D-zone testing for inducible clindamycin resistance is negative 1, 3
  • If inducible resistance is present or testing not performed: use vancomycin 1, 3

If GBS isolate is resistant to clindamycin OR susceptibility testing unavailable:

  • Vancomycin: 1 g IV every 12 hours until delivery 1, 3
  • Vancomycin is the default when susceptibility results are not available at labor onset 3

Critical Caveat on Clindamycin

Clindamycin demonstrates significantly lower effectiveness (22%, 95% CI -53% to +60%) compared to beta-lactams 2. Approximately 20% of GBS isolates are resistant to clindamycin, making susceptibility testing mandatory before use 4. Never use clindamycin without documented susceptibility 4.

Timing Requirements

Antibiotics must be administered at least 4 hours before delivery to achieve optimal effectiveness 1, 5, 3:

  • Prophylaxis <4 hours shows reduced effectiveness (47%, 95% CI -16% to +76%) 2
  • Prophylaxis <2 hours shows even lower effectiveness (38%, 95% CI -17% to +67%) 2
  • This 4-hour threshold applies to penicillin, ampicillin, cefazolin, vancomycin, and clindamycin 5, 3

Neonatal Treatment Regimens

For neonates with signs of sepsis:

  • Full diagnostic evaluation (blood culture, CBC with differential, chest radiograph if respiratory signs present, lumbar puncture if stable) 1, 4
  • Empirical therapy: Intravenous ampicillin PLUS an aminoglycoside (typically gentamicin) to cover GBS and gram-negative organisms including E. coli 1, 4
  • 15-38% of infants with early-onset meningitis have sterile blood cultures, making lumbar puncture essential for optimal diagnostic sensitivity 4

For well-appearing neonates born to mothers with suspected chorioamnionitis:

  • Limited evaluation (blood culture, CBC with differential at birth and/or 6-12 hours) 1
  • Empirical antibiotic therapy pending culture results 1, 4

Common Pitfalls to Avoid

  1. Do not use erythromycin for GBS prophylaxis - it is no longer acceptable due to increasing resistance 5, 3
  2. Do not give cefazolin to patients with urticaria history - this is an IgE-mediated reaction with high cross-reactivity risk 3
  3. Do not assume clindamycin susceptibility - resistance is present in ~20% of isolates and requires documented testing 4, 6
  4. Do not rely on intramuscular benzathine penicillin - it shows only 52% eradication versus 87% in controls and is insufficient as sole therapy 7

Indications for Intrapartum Prophylaxis

Administer prophylaxis when any of the following apply 4, 8:

  • Positive GBS vaginal-rectal culture within preceding 5 weeks
  • GBS bacteriuria during current pregnancy
  • Previous infant with GBS disease
  • Unknown GBS status with risk factors: <37 weeks gestation, rupture of membranes ≥18 hours, or intrapartum temperature ≥100.4°F (38.0°C)

References

Guideline

Antibiotic Prophylaxis for GBS‑Positive Pregnant Women with High‑Risk Penicillin Allergy (Urticaria)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Efficacy of intramuscular penicillin in the eradication of group B streptococcal colonization at delivery.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2005

Research

Group B Streptococcus in Pregnancy.

Obstetrics and gynecology clinics of North America, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.